Company intelligence / Profile preview

EnviroLogix

Portland, Maine, United Statesenvirologix.com ↗

Ownership: Private
Development stage: Commercial

Overview

EnviroLogix has over two decades of experience providing commercialized rapid diagnostic solutions—primarily point-of-use kits—for GMO trait, mycotoxin, pathogen, and protein detection in the global agricultural supply chain. Their technologies are widely adopted by seed companies, grain handlers, processors, and researchers to ensure quality control and regulatory compliance.

Modalities: Antibody (for immunoassays/ELISA/lateral flow devices)DNA detection assayRNA detection assayProtein detection assayLateral flow deviceELISA kitMolecular diagnostic technology
Industry: Agriculture & AgTech

Partnerships

Works with major agrobiotech corporations globally but specific partners not named in public sources.

Beyond the preview

Go deeper on EnviroLogix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EnviroLogix.

Explore the full profile